Location History:
- Sandwich, EN (1976 - 1977)
- Westgate-on-Sea, EN (1976 - 1978)
- Westgate-on-Sea, GB (1979)
- Ash, Nr. Canterbury, GB (1981)
Company Filing History:
Years Active: 1976-1981
Title: The Innovative Contributions of Anthony G Evans
Introduction
Anthony G Evans is a notable inventor based in Westgate-on-Sea, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of cardiac stimulants. With a total of 6 patents to his name, Evans has established himself as a key figure in medical innovation.
Latest Patents
Among his latest patents, Evans has developed a series of 1-piperidinophthalazine derivatives that serve as phosphodiesterase inhibitors and cardiac stimulants. This innovative work includes the patent for "Piperidinophthalazines as cardiac stimulants." Additionally, he has disclosed novel substituted compounds such as 1-phenyl-2-alkylamino-alkanols and 1-phenyl-2-alkylaminoalkanes, which are useful as heart stimulants.
Career Highlights
Evans is currently associated with Pfizer Corporation, a leading global pharmaceutical company. His work at Pfizer has allowed him to focus on groundbreaking research that aims to improve cardiac health and patient outcomes. His dedication to innovation in the pharmaceutical industry is evident through his numerous patents and ongoing research efforts.
Collaborations
Throughout his career, Evans has collaborated with esteemed colleagues, including Ian T Barnish and David A Cox. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and advancements in medical research.
Conclusion
Anthony G Evans is a distinguished inventor whose work in cardiac stimulants has made a significant impact on the pharmaceutical industry. His innovative patents and collaborations highlight his commitment to advancing medical science. His contributions continue to pave the way for future developments in cardiac health.